Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Published:2012-01 Issue:1 Volume:32 Page:80-94
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Shah Niren K.¹,Deeb Wasim E.¹²,Choksi Rushab¹,Epstein Benjamin J.³

Affiliation:

1. East Coast Institute for Research; Jacksonville Florida

2. The Division of Endocrinology; Baptist South Hospital; Jacksonville Florida

3. The Department of Pharmacotherapy and Translational Research; College of Pharmacy; University of Florida; Gainesville Florida

Publisher

Wiley

Subject

Pharmacology (medical)

Link

Reference76 articles.

2. Report of the expert committee on the diagnosis and classification of diabetes mellitus;Expert Committee on the Diagnosis and Classification of Diabetes Mellitus;Diabetes Care,2003

4. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy;The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group;N Engl J Med,2000

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献